MedTrace Logo

Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes

NCT06589141 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2024-09-19

No results posted yet for this study

Summary

This study aims to compare the maternal, fetal, and neonatal outcomes associated with the use of metformin versus glyburide for managing gestational diabetes.

The objective is to assess the safety and effectiveness profiles of both medications as potential alternatives to initiating insulin therapy.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Interventions

DRUG

MetFORMIN 500 Mg Oral Tablet

Metformin (500 to 2000 mg orally)

DRUG

GlyBURIDE 2.5 MG Oral Tablet

Glyburide (2.5 mg to 20 mg orally)

Sponsors & Collaborators

  • Middle-Eastern College of Obstetricians and Gynecologists

    collaborator OTHER

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-12-31
Completion
2026-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06589141 on ClinicalTrials.gov